CN103705461A - 一种脂微球制剂及其制备方法 - Google Patents
一种脂微球制剂及其制备方法 Download PDFInfo
- Publication number
- CN103705461A CN103705461A CN201410002897.1A CN201410002897A CN103705461A CN 103705461 A CN103705461 A CN 103705461A CN 201410002897 A CN201410002897 A CN 201410002897A CN 103705461 A CN103705461 A CN 103705461A
- Authority
- CN
- China
- Prior art keywords
- micro sphere
- propofol
- fat micro
- flurbiprofen
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 94
- 239000004005 microsphere Substances 0.000 title claims abstract description 84
- 150000002632 lipids Chemical class 0.000 title abstract description 9
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 claims abstract description 59
- 229960004134 propofol Drugs 0.000 claims abstract description 58
- 229960002390 flurbiprofen Drugs 0.000 claims abstract description 43
- 238000000034 method Methods 0.000 claims abstract description 25
- 239000000203 mixture Substances 0.000 claims abstract description 25
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 24
- 239000002904 solvent Substances 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 210000003022 colostrum Anatomy 0.000 claims abstract description 17
- 235000021277 colostrum Nutrition 0.000 claims abstract description 17
- 150000007942 carboxylates Chemical class 0.000 claims description 33
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 claims description 31
- 239000003381 stabilizer Substances 0.000 claims description 13
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 230000003444 anaesthetic effect Effects 0.000 claims description 10
- 229950005941 flurbiprofen axetil Drugs 0.000 claims description 10
- ALIVXCSEERJYHU-UHFFFAOYSA-N Flurbiprofen axetil Chemical compound FC1=CC(C(C)C(=O)OC(OC(C)=O)C)=CC=C1C1=CC=CC=C1 ALIVXCSEERJYHU-UHFFFAOYSA-N 0.000 claims description 7
- 239000003002 pH adjusting agent Substances 0.000 claims description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 4
- 239000000787 lecithin Substances 0.000 claims description 4
- 229940067606 lecithin Drugs 0.000 claims description 4
- 235000010445 lecithin Nutrition 0.000 claims description 4
- 229940060184 oil ingredients Drugs 0.000 claims description 4
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 2
- 102000002322 Egg Proteins Human genes 0.000 claims description 2
- 108010000912 Egg Proteins Proteins 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims description 2
- 210000004681 ovum Anatomy 0.000 claims description 2
- 239000008347 soybean phospholipid Substances 0.000 claims description 2
- -1 flurbiprofen ester Chemical class 0.000 abstract description 17
- 238000002156 mixing Methods 0.000 abstract description 2
- 239000003921 oil Substances 0.000 description 31
- 235000019198 oils Nutrition 0.000 description 31
- 238000002347 injection Methods 0.000 description 26
- 239000007924 injection Substances 0.000 description 26
- 238000012360 testing method Methods 0.000 description 18
- 208000002193 Pain Diseases 0.000 description 17
- 230000036407 pain Effects 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 230000000202 analgesic effect Effects 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 206010002091 Anaesthesia Diseases 0.000 description 8
- 230000037005 anaesthesia Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 230000001954 sterilising effect Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 208000000114 Pain Threshold Diseases 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000011737 fluorine Substances 0.000 description 5
- 229910052731 fluorine Inorganic materials 0.000 description 5
- 238000010253 intravenous injection Methods 0.000 description 5
- 230000037040 pain threshold Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 4
- 239000005642 Oleic acid Substances 0.000 description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 235000012424 soybean oil Nutrition 0.000 description 4
- 239000003549 soybean oil Substances 0.000 description 4
- 230000036592 analgesia Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000028527 righting reflex Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 206010003084 Areflexia Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000003708 ampul Substances 0.000 description 2
- 238000001949 anaesthesia Methods 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 210000002969 egg yolk Anatomy 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000005286 illumination Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011806 microball Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000003359 percent control normalization Methods 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000008215 water for injection Substances 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical group OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010022086 Injection site pain Diseases 0.000 description 1
- 238000012449 Kunming mouse Methods 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000000205 computational method Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 239000002869 intravenous anesthetic agent Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000008058 pain sensation Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000000528 statistical test Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
成分 | 用量 | 作用 |
丙泊酚 | 10g | 药物 |
氟比洛芬酯 | 10g | 药物 |
精制蛋黄卵磷脂 | 12g | 乳化剂 |
精制大豆油 | 100g | 油相溶剂 |
甘油 | 22.5g | 渗透压调节剂 |
油酸 | 0.3g | 稳定剂 |
氢氧化钠 | 适量 | pH调节剂 |
注射用水 | 稀释至1000ml | 溶剂 |
编号 | 1 | 2 | 3 | 平均(%) |
实施例1 | 97.8% | 98.6% | 98.4% | 98.3% |
实施例2 | 98.0% | 97.9% | 98.3% | 98.1% |
对照制剂1 | 92.6% | 92.1% | 92.5% | 92.3% |
编号 | 1 | 2 | 3 | 平均(%) |
实施例1 | 98.8% | 98.6% | 98.7% | 98.7% |
实施例2 | 98.6% | 98.3% | 98.5% | 98.4% |
对照制剂2 | 95.3% | 95.6% | 95.5% | 95.5% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410002897.1A CN103705461B (zh) | 2014-01-03 | 2014-01-03 | 一种脂微球制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410002897.1A CN103705461B (zh) | 2014-01-03 | 2014-01-03 | 一种脂微球制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103705461A true CN103705461A (zh) | 2014-04-09 |
CN103705461B CN103705461B (zh) | 2016-01-13 |
Family
ID=50399058
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410002897.1A Active CN103705461B (zh) | 2014-01-03 | 2014-01-03 | 一种脂微球制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103705461B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906050A (zh) * | 2015-06-30 | 2015-09-16 | 武汉大学 | 一种莲心碱脂微球制剂及其制备方法和用途 |
CN105753701A (zh) * | 2016-03-29 | 2016-07-13 | 广东嘉博制药有限公司 | 一种双效麻醉药物及其制备方法和用途 |
CN105919949A (zh) * | 2016-04-19 | 2016-09-07 | 北京泰德制药股份有限公司 | 一种稳定的氟比洛芬酯冻干乳及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199480A (zh) * | 2007-12-11 | 2008-06-18 | 西安力邦医药科技有限责任公司 | 一种含镇痛药的复方丙泊酚脂肪乳注射剂及制备方法 |
CN102188393A (zh) * | 2011-04-29 | 2011-09-21 | 武汉大安制药有限公司 | 一种氟比洛芬酯脂微球制剂 |
CN102805728A (zh) * | 2012-08-22 | 2012-12-05 | 南京正大天晴制药有限公司 | 一种丙泊酚脂肪乳注射液及其制备方法 |
-
2014
- 2014-01-03 CN CN201410002897.1A patent/CN103705461B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101199480A (zh) * | 2007-12-11 | 2008-06-18 | 西安力邦医药科技有限责任公司 | 一种含镇痛药的复方丙泊酚脂肪乳注射剂及制备方法 |
CN102188393A (zh) * | 2011-04-29 | 2011-09-21 | 武汉大安制药有限公司 | 一种氟比洛芬酯脂微球制剂 |
CN102805728A (zh) * | 2012-08-22 | 2012-12-05 | 南京正大天晴制药有限公司 | 一种丙泊酚脂肪乳注射液及其制备方法 |
Non-Patent Citations (1)
Title |
---|
赵小兵 等: "氟比洛芬酯联合止血带用于减轻丙泊酚注射痛的临床分析", 《齐齐哈尔医学院学报》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104906050A (zh) * | 2015-06-30 | 2015-09-16 | 武汉大学 | 一种莲心碱脂微球制剂及其制备方法和用途 |
CN104906050B (zh) * | 2015-06-30 | 2018-03-02 | 武汉大学 | 一种莲心碱脂微球制剂及其制备方法和用途 |
CN105753701A (zh) * | 2016-03-29 | 2016-07-13 | 广东嘉博制药有限公司 | 一种双效麻醉药物及其制备方法和用途 |
CN105753701B (zh) * | 2016-03-29 | 2018-08-03 | 广东嘉博制药有限公司 | 一种双效麻醉药物及其制备方法和用途 |
CN105919949A (zh) * | 2016-04-19 | 2016-09-07 | 北京泰德制药股份有限公司 | 一种稳定的氟比洛芬酯冻干乳及其制备方法 |
CN105919949B (zh) * | 2016-04-19 | 2018-10-16 | 北京泰德制药股份有限公司 | 一种稳定的氟比洛芬酯冻干乳及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103705461B (zh) | 2016-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102988291B (zh) | 一种氟比洛芬酯脂肪乳注射液组合物及其制备方法 | |
CN102448441B (zh) | 一种含有pH值调节剂的紫杉烷类药物溶液及其制备方法 | |
CN101480405A (zh) | 一种谷维素组合物及其制备方法 | |
CN100375621C (zh) | 长春瑞滨脂质微球注射液及其制备方法 | |
CN103705461B (zh) | 一种脂微球制剂及其制备方法 | |
WO2016198469A1 (en) | Penetration of alpha-hydroxy acids from water-free emulsions | |
CN1283235C (zh) | 清澈稳定的丙泊酚组合物 | |
CN101422431B (zh) | 胰岛素经鼻给药制剂 | |
CN101045042A (zh) | 丙泊酚注射液及制备方法 | |
CN107661294A (zh) | 抗高血压药物脂肪乳注射剂及其制备方法 | |
CN106074383B (zh) | 孕激素药物脂微球注射液及其制备方法 | |
KR101713219B1 (ko) | 포스파티딜콜린 및 리소포스파티딜콜린을 포함하는 주사제용 조성물 및 이의 제조방법 | |
CN104523591B (zh) | 无致敏性、无痛丙泊酚脂肪微乳冻干制剂配方和制备方法 | |
CN105770902B (zh) | 一种ω-3鱼油中长链脂肪乳注射液药物组合物及其制备方法 | |
CN105311622B (zh) | 一种治疗疼痛的联合用药物及其制剂、制备方法 | |
CN101322688B (zh) | 供静脉用氟马西尼的水包油乳剂及制备方法 | |
CN106109412A (zh) | 氟比洛芬酯脂微球注射液及其制备方法 | |
CN103054799B (zh) | 一种盐酸胺碘酮注射乳剂及其制备方法 | |
CN106137963B (zh) | 抗心律失常药物脂肪乳注射液及其制备方法 | |
CN102258467B (zh) | 静脉注射用缓释青蒿素及其衍生物脂肪乳的配方及制备 | |
CN111388418B (zh) | 一种含有罗哌卡因或其药用盐的药物组合物 | |
CN109260149B (zh) | 一种含有γ-生育三烯酚的纳米乳液及其制备方法和用途 | |
CN101632635A (zh) | 一种抗肿瘤乳剂及其制备方法 | |
CN105560216A (zh) | 一种恩替卡韦固体脂质纳米粒及其制备方法 | |
CN108653204B (zh) | 一种多烯磷脂酰胆碱注射液药物组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 430000 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee after: Yuanda Life Science (Wuhan) Co.,Ltd. Address before: 430040 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee before: WUHAN DOCAN PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: The invention relates to a lipid microsphere preparation and a preparation method thereof Effective date of registration: 20220224 Granted publication date: 20160113 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Yuanda Life Science (Wuhan) Co.,Ltd. Registration number: Y2022420000043 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230403 Granted publication date: 20160113 Pledgee: Wuhan area branch of Hubei pilot free trade zone of Bank of China Ltd. Pledgor: Yuanda Life Science (Wuhan) Co.,Ltd. Registration number: Y2022420000043 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
CP03 | Change of name, title or address |
Address after: 430000 No.1 Xiaoxiang West Road, Dongxihu District, Wuhan City, Hubei Province Patentee after: Yuanda Medical Nutrition Science (Wuhan) Co.,Ltd. Country or region after: China Address before: 430000 Jinyin Lake Ecological Park, Dongxihu District, Wuhan City, Hubei Province Patentee before: Yuanda Life Science (Wuhan) Co.,Ltd. Country or region before: China |
|
CP03 | Change of name, title or address |